References
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos- Blom MJ, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402–16.
Corso G, Robson ME, Sacchini V. Points to consider regarding risk-reducing mastectomy in high-, moderate-, and low-penetrance gene carriers. Ann Surg Oncol. 2022;29(9):5821–5.
Corso G, Magnoni F, Veronesi P. Points to consider regarding de-escalation surgery in high-risk breast cancer. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12542-9.
Magnoni F, Sacchini V, Veronesi P, et al. Surgical management of inherited breast cancer: role of breast-conserving surgery. Cancers (Basel). 2022;14(13):3245.
Morrow M. Surgery and prophylactic surgery in hereditary breast cancer. Breast. 2022;62(Suppl 1):S63–6.
Funding
This work was partially supported by the Italian Ministry of Health with Ricerca Corrente and 5×1000 funds.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Francesca Magnoni and Giovanni Corso declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Magnoni, F., Corso, G. ASO Author Reflections: Is Breast-Conserving Surgery a Safe Treatment Option for High-Risk Breast Cancer?. Ann Surg Oncol 29, 8090–8091 (2022). https://doi.org/10.1245/s10434-022-12589-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12589-8